Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.04 | 1.95 |
NAV | ₹19.57 | ₹431.89 |
Fund Started | 06 Oct 2020 | 04 Jun 1999 |
Fund Size | ₹153.72 Cr | ₹3459.68 Cr |
Exit Load | - | Exit load of 0.50% if redeemed within 15 days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 32.04% | 47.31% |
3 Year | 15.92% | 24.83% |
5 Year | - | 29.92% |
1 Year
3 Year
5 Year
Equity | 99.93% | 96.50% |
Cash | 0.01% | 3.50% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.34% |
Cipla Ltd. | 6.12% |
Max Healthcare Institute Ltd. | 5.95% |
Dr. Reddy's Laboratories Ltd. | 5.59% |
Apollo Hospitals Enterprise Ltd. | 5.31% |
Divi's Laboratories Ltd. | 5.29% |
Eli Lilly And Co | 5.09% |
Lupin Ltd. | 3.75% |
Johnson & Johnson Ltd. | 2.89% |
Aurobindo Pharma Ltd. | 2.77% |
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 12.87% |
Divi's Laboratories Ltd. | 6.42% |
Cipla Ltd. | 5.68% |
Max Healthcare Institute Ltd. | 5.66% |
Lupin Ltd. | 4.74% |
Lonza Group Ag | 4.39% |
Poly Medicure Ltd. | 4.02% |
Krishna Institute of Medical Sciences Ltd | 3.75% |
Jupiter Life Line Hospitals Ltd. | 3.64% |
Aether Industries Ltd. | 3.33% |
Name | Bhavesh Jain | Tanmaya Desai |
Start Date | 01 Oct 2021 | 27 Jun 2011 |
Name
Start Date
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 06 Oct 2020 | 04 Jun 1999 |
Description
Launch Date